Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Reperfusion of ischemia in the heart or brain.
Journal: The Journal of pharmacology and experimental therapeutics
Published: October 29, 2024
Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown.
Journal: Cardiovascular drugs and therapy
Published: January 04, 2020
Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination.
Journal: Journal of thrombosis and thrombolysis
Published: June 11, 2017
A first-in-human study of DS-1040, an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor, in healthy subjects: comment.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 08, 2017
Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII: comment.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 02, 2016
Therapeutic Fibrinolysis: How Efficacy and Safety Can Be Improved.
Journal: Journal of the American College of Cardiology
Published: July 14, 2016
Structure-function relationships in thrombin-activatable fibrinolysis inhibitor: comment.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 24, 2016
Thrombolysis: A Critical First-Line Therapy with an Unfulfilled Potential.
Journal: The American journal of medicine
Published: November 12, 2015
Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement.
Journal: Journal of thrombosis and thrombolysis
Published: April 21, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026